Grimes DA - Search Results

1

A Nurr1 point mutant, implicated in Parkinson's disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription.

Jacobsen KX, MacDonald H, Lemonde S, Daigle M, Grimes DA, Bulman DE, Albert PR. Jacobsen KX, et al. Among authors: grimes da. Neurobiol Dis. 2008 Jan;29(1):117-22. doi: 10.1016/j.nbd.2007.08.003. Epub 2007 Aug 21. Neurobiol Dis. 2008. PMID: 17890097

2

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.

Grimes DA, Han F, Panisset M, Racacho L, Xiao F, Zou R, Westaff K, Bulman DE. Grimes DA, et al. Mov Disord. 2006 Jul;21(7):906-9. doi: 10.1002/mds.20820. Mov Disord. 2006. PMID: 16532445

3

Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.

Han F, Grimes DA, Li F, Wang T, Yu Z, Song N, Wu S, Racacho L, Bulman DE. Han F, et al. Among authors: grimes da. Int J Neurosci. 2016;126(5):415-21. doi: 10.3109/00207454.2015.1023436. Epub 2015 Aug 18. Int J Neurosci. 2016. PMID: 26000814

4

Refinement of the DYT15 locus in myoclonus dystonia.

Han F, Racacho L, Lang AE, Bulman DE, Grimes DA. Han F, et al. Among authors: grimes da. Mov Disord. 2007 Apr 30;22(6):888-92. doi: 10.1002/mds.21400. Mov Disord. 2007. PMID: 17274032

5

Large deletions account for an increasing number of mutations in SGCE.

Han F, Racacho L, Yang H, Read T, Suchowersky O, Lang AE, Grimes DA, Bulman DE. Han F, et al. Among authors: grimes da. Mov Disord. 2008 Feb 15;23(3):456-60. doi: 10.1002/mds.21895. Mov Disord. 2008. PMID: 18098280

6

Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease.

Shi G, Lee JR, Grimes DA, Racacho L, Ye D, Yang H, Ross OA, Farrer M, McQuibban GA, Bulman DE. Shi G, et al. Among authors: grimes da. Hum Mol Genet. 2011 May 15;20(10):1966-74. doi: 10.1093/hmg/ddr077. Epub 2011 Feb 25. Hum Mol Genet. 2011. PMID: 21355049

7

Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.

Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. Mount MP, et al. J Neurosci. 2007 Mar 21;27(12):3328-37. doi: 10.1523/JNEUROSCI.5321-06.2007. J Neurosci. 2007. PMID: 17376993 Free PMC article.

8

Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Lach B, Grimes D, Benoit B, Minkiewicz-Janda A. Lach B, et al. Acta Neuropathol. 1992;83(4):352-60. doi: 10.1007/BF00713525. Acta Neuropathol. 1992. PMID: 1374203

9

Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Montero-Odasso M, Pieruccini-Faria F, Bartha R, Black SE, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McLaughlin PM, Munoz DP, Strother S, Swartz RH, Symons S, Tartaglia MC, Zinman L, Strong MJ; ONDRI Investigators; McIlroy W. Montero-Odasso M, et al. Among authors: grimes da. J Alzheimers Dis. 2017;59(2):707-721. doi: 10.3233/JAD-170149. J Alzheimers Dis. 2017. PMID: 28671116 Free PMC article.

10

Deprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects.

Vezina P, Mohr E, Grimes D. Vezina P, et al. Can J Neurol Sci. 1992 Feb;19(1 Suppl):142-6. Can J Neurol Sci. 1992. PMID: 1571860 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

479 results

Search Page